Twist Bioscience Corp — Director's Dealing 2021

Mar 5, 2021

SEC Form 4/A — Form 4/A

Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2019-05-20

Reporting Person: CHAN NELSON C (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-05-20	Director Stock Option (right to buy)	$25.29	A	23033	Acquired	2029-05-19	Common Stock (23033)	Direct

Footnotes

F1: The Form 4 originally filed on August 29, 2019 incorrectly reported 13,444 options.

F2: 1/3rd of the shares subject to the option will vest and become exercisable on May 20, 2020 and each annual anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.